AnaptysBio (ANAB) PT Lowered to $66 at JPMorgan
Get Alerts ANAB Hot Sheet
Price: $55.28 -3.07%
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
13 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
JPMorgan analyst Anupam Rama lowered the price target on AnaptysBio (NASDAQ: ANAB) to $66.00 (from $75.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- MiniMed Group (MMED) PT Raised to $28 at BTIG
- Medtronic, Inc. (MDT) PT Raised to $100 at BTIG
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share